No abstract available
Keywords:
FDA; clinical trial; diabetes; drug; hypoglycemia.
MeSH terms
-
Biomarkers / blood
-
Blood Glucose / drug effects*
-
Blood Glucose / metabolism
-
Clinical Trials as Topic*
-
Diabetes Mellitus, Type 1 / blood
-
Diabetes Mellitus, Type 1 / diagnosis
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Endpoint Determination
-
Glycemic Control / adverse effects*
-
Humans
-
Hypoglycemia / blood
-
Hypoglycemia / chemically induced
-
Hypoglycemia / diagnosis
-
Hypoglycemia / prevention & control*
-
Hypoglycemic Agents / adverse effects*
-
Research Design*
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome
Substances
-
Biomarkers
-
Blood Glucose
-
Hypoglycemic Agents